Related Experiment Video
Updated: Mar 22, 2026

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
How sodium arsenite improve amyloid β-induced memory deficit?
Ehsan Nassireslami1, Parmida Nikbin1, Elham Amini1
1Department of Pharmacology and Toxicology, Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
High arsenic doses impair memory, while low doses protect against beta-amyloid-induced deficits by modulating key molecular pathways. This suggests concentration-dependent neuroprotective effects of sodium arsenite.
Area of Science:
- Neuroscience
- Toxicology
- Molecular Biology
Background:
- Arsenic exposure is linked to cognitive deficits, but its molecular mechanisms remain unclear.
- Understanding arsenic's impact on learning and memory is crucial for public health.
Purpose of the Study:
- To investigate the concentration-dependent effects of sodium arsenite on memory in rats.
- To explore the molecular mechanisms underlying arsenic's influence on memory, particularly in the context of beta-amyloid (Aβ) exposure.
Main Methods:
- Male rats were subjected to Pavlovian fear conditioning to assess contextual and tone memory.
- Sodium arsenite (1, 5, 10, 100nM) was administered alone and with Aβ.
- Western blot analysis was used to measure levels of caspase-3, NF-κB, CREB, HO-1, and Nrf2.
Main Results:
- High doses of sodium arsenite significantly impaired memory 9 and 16 days post-administration.
- Low doses of sodium arsenite attenuated Aβ-induced memory deficits after 16 days.
- High arsenic doses increased caspase-3 and NF-κB; low doses activated Nrf2, HO-1, and CREB phosphorylation in the hippocampus.
Conclusions:
- Sodium arsenite exhibits concentration-dependent effects on contextual and tone memory.
- Ultra-low concentrations of sodium arsenite may offer neuroprotection against Aβ-induced memory impairment.
- Neuroprotection is potentially mediated by increased Nrf2, HO-1, CREB phosphorylation, and decreased caspase-3 and NF-κB levels.
More Related Videos
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Role of Amygdala in Memory
One of the...